Abstract P1-14-01: First report of clinicopathological analysis in neoadjuvant treatment phase in NEOS: A randomized study of adjuvant endocrine therapy with or without chemotherapy for postmenopausal breast cancer patients who responded to neoadjuvant letrozole

Treatment Phase ◽

Breast Cancer Patients ◽

First Report ◽

Clinicopathological Analysis

P3-15-01: An Interim Efficacy Analysis of Neoadjuvant Letrozole in the New Primary Endocrine-Therapy Origination Study (NEOS/N-SAS BC06): A Randomized Study of Adjuvant Endocrine Therapy with or without Chemotherapy for Postmenopausal Breast Cancer Patients Who Responded to Neoadjuvant Letrozole.

10.1158/0008-5472.sabcs11-p3-15-01 ◽

2011 ◽

Author(s):

H Iwata ◽

T Yamaguchi ◽

N Masuda ◽

T Toyama ◽

M Kashiwaba ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Endocrine Therapy ◽

Randomized Study ◽

Breast Cancer Patients ◽

Efficacy Analysis ◽

Primary Endocrine Therapy

Corrigendum to “Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study” [The Breast, 44, April 2019, 52–58]

The Breast ◽

10.1016/j.breast.2019.03.007 ◽

2019 ◽

Vol 45 ◽

pp. 118

Author(s):

Kari Britt Hagen ◽

Turid Aas ◽

Jan Terje Kvaløy ◽

Håvard Søiland ◽

Ragna Lindb

Keyword(s):

Breast Cancer ◽

Prospective Study ◽

Cancer Patients ◽

Endocrine Therapy ◽

CYP2D6 Genotype Should Not Be Used to Determine Endocrine Therapy in Postmenopausal Breast Cancer Patients

Clinical Pharmacology & Therapeutics ◽

10.1038/clpt.2013.102 ◽

2013 ◽

Vol 94 (2) ◽

pp. 183-185 ◽

Cited By ~ 9

Author(s):

J M Rae

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Endocrine Therapy ◽

Cyp2d6 Genotype ◽

Abstract PD09-05: Impact of Body Mass Index (BMI) on the Efficacy of Endocrine Therapy in Postmenopausal Breast Cancer Patients — An Analysis of the ABCSG 6 and 6a Trial

10.1158/0008-5472.sabcs10-pd09-05 ◽

2010 ◽

Cited By ~ 2

Author(s):

G Pfeiler ◽

H Stöger ◽

C Singer ◽

M Seifert ◽

R Jakesz ◽

...

Keyword(s):

Breast Cancer ◽

Body Mass Index ◽

Cancer Patients ◽

Endocrine Therapy ◽

Body Mass ◽

Abstract P5-11-10: Gonadotropins Plasma Levels Are Significantly Influenced by Body Mass Index in Postmenopausal Breast Cancer Patients Undergoing Endocrine Therapy with Aromatase Inhibitors: Is This a Surrogate Marker for Serum Estrogen Bioactivity?

10.1158/0008-5472.sabcs10-p5-11-10 ◽

2010 ◽

Author(s):

M Hubalek ◽

A Oberguggenberger ◽

B Beer ◽

V Meraner ◽

H Oberacher ◽

...

Keyword(s):

Breast Cancer ◽

Body Mass Index ◽

Cancer Patients ◽

Endocrine Therapy ◽

Body Mass ◽

Aromatase Inhibitors ◽

Plasma Levels ◽

Surrogate Marker ◽

Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study

The Breast ◽

10.1016/j.breast.2019.01.003 ◽

2019 ◽

Vol 44 ◽

pp. 52-58 ◽

Cited By ~ 3

Author(s):

Kari Britt Hagen ◽

Turid Aas ◽

Jan Terje Kvaløy ◽

Håvard Søiland ◽

Ragna Lind

Keyword(s):

Breast Cancer ◽

Prospective Study ◽

Cancer Patients ◽

Endocrine Therapy ◽

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-1235-y ◽

2010 ◽

Vol 126 (1) ◽

pp. 221-226 ◽

Cited By ~ 46

Author(s):

Kelly-Anne Phillips ◽

Julie Aldridge ◽

Karin Ribi ◽

Zhuoxin Sun ◽

Alastair Thompson ◽

...

Keyword(s):

Breast Cancer ◽

Cognitive Function ◽

Cancer Patients ◽

Endocrine Therapy ◽

Breast Cancer Patients ◽

One Year

Faculty Opinions recommendation of Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13357185.14726525 ◽

2011 ◽

Author(s):

Gretchen Kimmick ◽

Elizabeth Bigger

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Cancer Patients ◽

Endocrine Therapy ◽

Meta Analysis ◽

P4-16-04: An Open-Label, Phase IIa, Non-Randomized Study of Radium-223 in Breast Cancer Patients with Bone Dominant Disease No Longer Considered Suitable for Endocrine Therapy.

10.1158/0008-5472.sabcs11-p4-16-04 ◽

2011 ◽

Cited By ~ 1

Author(s):

R Coleman ◽

P Flamen ◽

B Naume ◽

G Jerusalem ◽

C Garcia ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Endocrine Therapy ◽

Randomized Study ◽

Breast Cancer Patients ◽

Open Label ◽

Radium 223 ◽

Open Label Phase ◽

Dominant Disease

Abstract S2-7: Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients

10.1158/0008-5472.sabcs10-s2-7 ◽

2010 ◽

Cited By ~ 4

Author(s):

E Amir ◽

A Ocaña ◽

S Niraula ◽

L Carlsson ◽

B. Seruga

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Endocrine Therapy ◽